TEAD4 and metabolic dysfunction-associated steatotic liver disease: Notably, TEAD4 shows contrasting expression patterns in NAFLD and liver cancer (Fig. 7A–F), suggesting its regulatory role in the progression from NAFLD to liver cancer.